Analyst Activity – J P Morgan Chase & Co Reiterates Overweight on Ironwood Pharmaceuticals (NASDAQ:IRWD)

Analyst Ratings For Ironwood Pharmaceuticals (NASDAQ:IRWD)

Story continues below

Today, J P Morgan Chase & Co reiterated its Overweight rating on Ironwood Pharmaceuticals (NASDAQ:IRWD).

There are 5 hold ratings, 4 buy ratings on the stock.

The current consensus rating on Ironwood Pharmaceuticals (NASDAQ:IRWD) is Hold (Score: 2.44) with a consensus target price of $18.44 per share, a potential 8.50% upside.

Some recent analyst ratings include

  • 7/21/2017-J P Morgan Chase & Co Reiterated Rating of Overweight .
  • 6/16/2017-Wedbush Reiterated Rating of Neutral.
  • 5/9/2017-Cowen and Company Reiterated Rating of Outperform.
  • 5/3/2017-Wells Fargo & Company initiated coverage with a Outperform rating.
  • 3/13/2017-BTIG Research Reiterated Rating of Buy.
  • 2/22/2017-Barclays PLC Reiterated Rating of Equal Weight .

Recent Insider Trading Activity For Ironwood Pharmaceuticals (NASDAQ:IRWD)
Ironwood Pharmaceuticals (NASDAQ:IRWD) has insider ownership of 7.63% and institutional ownership of 97.36%.

  • On 6/22/2017 Halley E Gilbert, Insider, sold 35,000 with an average share price of $19.75 per share and the total transaction amounting to $691,250.00. View SEC Filing
  • On 5/15/2017 Thomas A Mccourt, Insider, sold 30,000 with an average share price of $18.20 per share and the total transaction amounting to $546,000.00. View SEC Filing
  • On 2/14/2017 Halley E Gilbert, Insider, sold 37,385 with an average share price of $16.75 per share and the total transaction amounting to $626,198.75. View SEC Filing
  • On 1/12/2017 Peter M Hecht, CEO, sold 65,987 with an average share price of $15.67 per share and the total transaction amounting to $1,034,016.29. View SEC Filing
  • On 12/5/2016 Lawrence S Olanoff, Director, sold 3,200 with an average share price of $15.68 per share and the total transaction amounting to $50,176.00. View SEC Filing
  • On 9/6/2016 Lawrence S Olanoff, Director, sold 3,200 with an average share price of $13.72 per share and the total transaction amounting to $43,904.00. View SEC Filing
  • On 8/19/2016 Gina Consylman, Insider, sold 207 with an average share price of $13.54 per share and the total transaction amounting to $2,802.78. View SEC Filing

Recent Trading Activity for Ironwood Pharmaceuticals (NASDAQ:IRWD)
Shares of Ironwood Pharmaceuticals closed the previous trading session at 17.00 0.00 0.00% with 6,408,355 shares trading hands.

An ad to help with our costs